Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Appleby updates on current state of co-operation agreements between the EU and third country regulators on AIFMD

Tuesday, June 04, 2013

Beverly Chandler, Opalesque London: Offshore financial services law firm, Appleby has published a note regarding the EU’s AIFMD legislation and the co-operation agreements with the regulators of third countries, outside of the EU.

With AIFMD due to be implemented across Europe by 22 July 2013, the European Securities and Markets Authority (ESMA) has already approved co-operation agreements between EU securities regulators (and authorities from Croatia, Iceland, Liechtenstein and Norway) and 34 of their global counterparts including:

  • Bermuda, where Appleby describes the co-operation agreement with the Bermuda Monetary Authority as an extremely good development for Bermuda, 'and shows the continued pro-activity of the Bermuda regulator and its willingness to engage the private sector in meeting the demands of industry'.

  • British Virgin Islands

  • Cayman Islands: here, Appleby writes: "In order that the Cayman Islands Monetary Authority has the necessary powers to meet its obligations under the co-operation agreements, The Monetary Authority Law of the Cayman Islands was amended by The Monetary Authority (Amendment) Law 2013, permitting the Cayman Islands Monetary Authority to enter into memoranda of understanding in relation to cross-border supervision; to allow overseas regulatory authorities to carry out on-site inspections; to apply to the Grand Court of the Cayman Islands for orders to ......................

    To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for